Abstract 33P
Background
Three-dimensional (3D) cultures use the property of some cells to self-organize in generate structures that can be programmed to represent an organ or a pathology. The ductal compartment in salivary gland has been identified as the location harboring stem cells.Salivary glands has been investigated using in vivo or ex vivo rudiment culture models. The specific requirements of the niche remain unclear for many cell types, including the pro-acinar cells that give rise to secretory acinar epithelial cells that produce saliva. Organoid cultures are the 3D cultivation of source tissue in a support matrix and specialized media that nearly resembles the physiological environment. Tumor organoids are 3D cultures of cancer cells that can be derived on an individual patient basis with a high success rate. This creates opportunities to build large biobanks with relevant patient material that can be used to perform drug screens and facilitate drug development. In this study, we highlight what is currently known about tumor organoid culture, the advantages of the model system, biobanks of patient-derived tumor organoids are used in drug development research.
Methods
Human salivary gland stem cells (SGSCs) were cultured in 3D tissue cultures with Wnt3a-containing medium. SGSCs were aggregated and formed into 3D spheroid structure in tissue culture plastic (TCP). The SGSC spheroids assembled in 3D tissue culture expressed the significantly higher SGSC and pleuripotency related gene and protein levels.
Results
As a result, we established a tumor organoid model using a three-dimensional (3D) salivary gland organoid culture system. In addition, organoid biobanking was established for patient-specific treatment through analysis and development of various types of tumors.
Conclusions
In conclusion, Tumor organoids are 3D cultures of cancer cells that can be derived on an individual patient basis with a high success rate. This creates opportunities to build large biobanks with relevant patient material that can be used to perform drug screens and facilitate drug development. In addition, it will make a great contribution to the development of patient-specific treatments through biobanking.
Clinical trial identification
Editorial acknowledgement
This work was supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government(MSIT) (No. 2019R1C1C1006223).
Legal entity responsible for the study
Chung-Ang University.
Funding
Ministry of Science and ICT (The National Research Foundation of Korea). This work was supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government(MSIT) (No. 2019R1C1C1006223).
Disclosure
The author has declared no conflicts of interest.
Resources from the same session
6P - Deep learning radiomics supports perioperative treatment decisions and is associated with LncRNAs in breast cancer: A multicenter study
Presenter: Yunfang Yu
Session: Poster viewing 01
7P - Predicting lymph node metastasis and molecular subtype from pathology united with genomics in breast cancer with multitask deep learning
Presenter: Zehua Wang
Session: Poster viewing 01
8P - Dismantling the role of liquid biopsy in predicting outcome of patients with early-stage breast cancer following neoadjuvant therapy: A systematic review
Presenter: Jeremiah Wijaya
Session: Poster viewing 01
9P - Development and validation of a pathogenomics model to improve the risk stratification of breast cancer: A deep learning study
Presenter: lin ruichong
Session: Poster viewing 01
10P - Enriched gut microbiota increases anticancer drug efficacy in breast cancer cell lines: A promising in vitro approach
Presenter: Selvaraj Jayaraman
Session: Poster viewing 01
11P - Preservation of intercostobrachial nerve during axillary lymph node dissection in breast cancer patients positively impacts chronic pain, sensory changes, and quality of life: Should it be the standard?
Presenter: Ajai Sasidhar
Session: Poster viewing 01
12P - Non-clinical factors influencing patient’s choice of mastectomy over breast conservation among Indian women with breast cancer
Presenter: Nivedita Sharma
Session: Poster viewing 01
13P - Hypofractionated radiotherapy in post operative breast cancer patients: 3-year clinical experience in a newly established cancer center
Presenter: Shaila Sharmin
Session: Poster viewing 01
14P - The impact of the deep inspiration breath-hold (DIBH) technique in the heart and other organ-at-risk (OAR) dose sparing in the postoperative radiotherapy to the left early breast cancer
Presenter: Hui-Ling Yeh
Session: Poster viewing 01
15P - Delays in breast cancer treatment in a tertiary hospital
Presenter: Rogelio Velasco
Session: Poster viewing 01